为观察丙氨瑞林(国产 GnRHa)治疗子宫内膜异位症的疗效及副作用,以7例丹哪唑组为对照组,丙氨瑞林组14例连续治疗3个月。用药期间观察症状和体征,盆腔 B 超检查,测定性激素和肝肾功能等指标。结果表明丙氨瑞林明显减少月经量,痛经减轻,半数患者盆腔肿块缩小。治疗总有效率为92.31%。丙氨瑞林药效略优于丹哪唑(85.71%),无明显副作用。结果提示丙氨瑞林用于治疗子宫内膜异位症安全有效,且略优于丹哪唑。 To observe the curative effect and side effects of ararelin (endogenous GnRHa) for endometriosis, 7 cases of danazol group as the control group, 14 cases of continuous treatment of alarelin group for 3 months. Observation of symptoms and signs during treatment, pelvic ultrasound B, determination of sex hormones and liver and kidney function and other indicators. The results showed that arelin Reilin significantly reduce menstrual flow, reduce dysmenorrhea, pelvic mass reduction in half of patients. The total effective rate was 92.31%. Alarelin slightly better efficacy than danazol (85.71%), no significant side effects. The results suggest that the use of ararelin in the treatment of endometriosis is safe and effective, and is slightly superior to danazol.